Thrombotic thrombocytopenic purpura secondary prevention

Xyz Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Xyz from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Thrombotic thrombocytopenic purpura secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Thrombotic thrombocytopenic purpura secondary prevention
CDC on Thrombotic thrombocytopenic purpura secondary prevention
Thrombotic thrombocytopenic purpura secondary prevention in the news
Blogs on Thrombotic thrombocytopenic purpura secondary prevention
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Thrombotic thrombocytopenic purpura secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

Effective measures for the secondary prevention of TTP include: prevention any further clinically significant allergic or anaphylactic reactions and facilitated both patients’ TTP (inherited and acquired thrombotic thrombocytopenic purpura) remissions.

Secondary Prevention

Effective measures for the secondary prevention of TTP is prevention any further clinically significant allergic or anaphylactic reactions and facilitated both patients’ TTP (inherited and acquired thrombotic thrombocytopenic purpura) remissions. Patients who had TTP should be obsereved for signs and symptoms of relapse.

• Factors that may trigger TTP or relapse, including:
  • Pregnancy
  • Diseases such as cancer, HIV, lupus and infections.
  • Medical procedures, such as surgery, blood and marrow stem cell transplant.
  • Medicines, such as ticlopidine, clopidogrel, cyclosporine A, chemotherapy, and hormone therapy(estrogens).
  • Quinine